Skip to content

Based on my review of the GO-CAM model and the related literature, I will now provide a detailed analysis of gomodel:66187e4700001597 "The growth hormone receptor signaling pathway (Human)".

GO-CAM Review: The Growth Hormone Receptor Signaling Pathway (Human)

Summary

This GO-CAM model (gomodel:66187e4700001597) represents the human growth hormone receptor signaling pathway, focusing on key molecular components and their causal relationships in the signaling cascade. The model includes four primary activities:

  1. Growth factor activity of GH1
  2. Growth hormone receptor activity of GHR
  3. Non-membrane spanning protein tyrosine kinase activity of JAK2
  4. DNA-binding transcription factor activity of STAT5B

Overall Assessment

The model presents a sound representation of the growth hormone signaling pathway, accurately capturing the key components and causal relationships. It adheres to GO-CAM best practices and is biologically consistent with current literature.

Strengths

  1. Accurate representation of signaling cascade: The model correctly captures the flow of signaling from the extracellular growth hormone (GH1) through the membrane receptor (GHR), to downstream kinase activation (JAK2), and ultimately to transcriptional regulation (STAT5B).

  2. Appropriate use of GO terms: The model uses appropriate GO molecular function terms for each component.

  3. Correct cellular compartmentalization: Each component is appropriately localized (GH1 in extracellular space, GHR in plasma membrane, JAK2 at the cytoplasmic side of plasma membrane, and STAT5B in the nucleus).

  4. Well-supported by evidence: Each assertion is backed by literature evidence with appropriate references.

  5. Correct causal connections: The relationships between components accurately reflect the known signaling cascade, with proper use of causal predicates.

Detailed Analysis

1. GH1 (Growth Hormone) Activity

  • Function: GO:0008083 (growth factor activity)
  • Location: GO:0005615 (extracellular space)
  • Part of: GO:0060396 (growth hormone receptor signaling pathway)
  • Evidence: ECO:0000314 (direct assay evidence used in manual assertion) from PMID:1549776
  • Causal relationship: Directly positively regulates (RO:0002629) GHR activity

This representation is accurate. Growth hormone (GH1) secreted into the extracellular space binds to its receptor on the cell surface and initiates signaling. The paper by de Vos et al. (1549776) provides strong evidence for this interaction through crystal structure analysis of the complex.

2. GHR (Growth Hormone Receptor) Activity

  • Function: GO:0004903 (growth hormone receptor activity)
  • Location: GO:0005886 (plasma membrane)
  • Part of: GO:0060396 (growth hormone receptor signaling pathway)
  • Evidence: ECO:0000314 (direct assay evidence used in manual assertion) from PMID:2825030
  • Causal relationship: Directly positively regulates (RO:0002629) JAK2 activity

This representation is correct. GHR is properly localized to the plasma membrane, and its primary function in binding growth hormone is accurately depicted. The reference Leung et al. (2825030) provides direct evidence for GHR function and localization.

3. JAK2 (Janus Kinase 2) Activity

  • Function: GO:0004715 (non-membrane spanning protein tyrosine kinase activity)
  • Location: GO:0031234 (extrinsic component of cytoplasmic side of plasma membrane)
  • Part of: GO:0060397 (growth hormone receptor signaling pathway via JAK-STAT)
  • Evidence: ECO:0000314 (direct assay evidence used in manual assertion) from PMID:15690087
  • Causal relationship: Provides input for (RO:0002407) STAT5B activity

The model correctly represents JAK2 as a cytoplasmic tyrosine kinase that associates with the cytoplasmic domain of GHR. The evidence from Greenhalgh et al. (15690087) provides solid support for JAK2's role in this pathway. The subcellular localization is supported by PMID:8007942 (Mui et al.), which demonstrates that JAK2 associates with the membrane-proximal region of cytokine receptors.

4. STAT5B (Signal Transducer and Activator of Transcription 5B) Activity

  • Function: GO:0003700 (DNA-binding transcription factor activity)
  • Location: GO:0005634 (nucleus)
  • Part of: GO:0060397 (growth hormone receptor signaling pathway via JAK-STAT)
  • Evidence: ECO:0000304 (author statement supported by traceable reference) from PMID:8631883

The representation of STAT5B is accurate. Upon phosphorylation by JAK2, STAT5B dimerizes and translocates to the nucleus where it acts as a transcription factor. The evidence from PMID:8631883 (Lin et al.) supports this function. The nuclear localization is supported by PMID:29844444, which discusses the translocation of STAT5B to the nucleus in response to phosphorylation.

Pathway Completeness

The model captures the core components of the GH signaling pathway. A few additional elements that could potentially enhance the model include:

  1. The dimerization of GHR upon GH binding
  2. Specific phosphorylation sites on JAK2 and STAT5B
  3. Downstream targets of STAT5B transcriptional activity
  4. Negative regulators of the pathway such as SOCS proteins

Consistency with GO-CAM Best Practices

The model follows GO-CAM best practices for:

  1. Signaling receptor activity annotation: The model correctly represents the relationship between the ligand (GH1) and its receptor (GHR), consistent with the guidelines in the "Signaling receptor activity annotation guidelines" document.

  2. DNA-binding transcription factor activity: The representation of STAT5B follows the guidelines specified in the "DNA-binding transcription factor activity annotation guidelines" document.

  3. Causal relationships: The model uses appropriate causal predicates to connect activities in the pathway.

Recommendations for Improvement

  1. Consider adding receptor dimerization: The literature (PMID:1549776) indicates that one GH molecule binds two GHR molecules, forming a 1:2 complex. This could be explicitly modeled.

  2. Include negative regulation: The pathway is regulated by negative feedback through SOCS proteins, particularly SOCS2 as indicated in PMID:15690087 and PMID:12552091. Adding these regulatory components would enhance the model's completeness.

  3. Add specific phosphorylation sites: The model could be enhanced by indicating the specific phosphorylation sites on JAK2 (Tyr1007/1008) and STAT5B (Tyr699).

  4. Include more downstream effects: The model could be expanded to include specific gene targets activated by STAT5B to provide a more complete picture of the biological outcomes of GH signaling.

Conclusion

The GO-CAM model "The growth hormone receptor signaling pathway (Human)" (gomodel:66187e4700001597) is a scientifically accurate and well-structured representation of the core GH signaling pathway. It follows GO-CAM best practices and is supported by appropriate evidence from the literature. While a few additional components could be added to enhance completeness, the current model effectively captures the key molecular activities and causal relationships in this important signaling pathway.